SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) announced today that Michael Morrissey, Ph.D., the company’s president and chief executive officer, will present at the upcoming Bank of America Merrill Lynch Health Care Conference at 11:40 a.m. EDT / 8:40 a.m. PDT on Tuesday, May 10, 2011 in Las Vegas. During the presentation, Dr. Morrissey will review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer (CRPC) and discuss the pivotal trial plans and regulatory strategy for the compound in CRPC. He will also discuss the company’s 2011 financial outlook and provide a general business update.
